(CACI) CACI International - Ratings and Ratios
Cybersecurity, Intelligence, Digital IT, Defense
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 26.5% |
| Value at Risk 5%th | 39.3% |
| Relative Tail Risk | -9.74% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.87 |
| Alpha | 21.09 |
| CAGR/Max DD | 0.56 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.460 |
| Beta | 0.340 |
| Beta Downside | 0.084 |
| Drawdowns 3y | |
|---|---|
| Max DD | 42.88% |
| Mean DD | 9.62% |
| Median DD | 6.01% |
Description: CACI CACI International October 30, 2025
CACI International Inc. (NYSE:CACI) delivers a portfolio of technology and engineering services to U.S. federal agencies and allied governments, spanning cyber-defense, intelligence-fusion, enterprise IT, mission-critical engineering, and spectrum-superiority solutions. Its offerings range from offensive/defensive cyber operations and secure network infrastructure to naval architecture, training simulators, and proprietary data analytics platforms.
In FY 2023 the company reported $6.1 billion in revenue, with a backlog of roughly $8 billion-indicating strong demand continuity. Operating margins have hovered near 11%, while cash flow conversion exceeds 80%, supporting ongoing R&D investment. Key economic drivers include the U.S. defense budget’s multi-year rise (projected > $800 billion by 2028) and accelerating federal cyber-spending, which together underpin CACI’s growth outlook in the IT-consulting and defense-technology sub-industry.
For a deeper quantitative view, the ValueRay platform provides a granular breakdown of CACI’s valuation multiples and scenario analysis, helping you assess the stock’s risk-adjusted upside.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income (504.5m TTM) > 0 and > 6% of Revenue (6% = 531.5m TTM) |
| FCFTA 0.07 (>2.0%) and ΔFCFTA 1.45pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 7.38% (prev 9.48%; Δ -2.10pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.08 (>3.0%) and CFO 683.4m > Net Income 504.5m (YES >=105%, WARN >=100%) |
| Net Debt (3.07b) to EBITDA (1.01b) ratio: 3.03 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.54 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (22.2m) change vs 12m ago -1.65% (target <= -2.0% for YES) |
| Gross Margin 8.99% (prev 8.80%; Δ 0.19pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 111.5% (prev 109.5%; Δ 2.00pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 4.40 (EBITDA TTM 1.01b / Interest Expense TTM 181.0m) >= 6 (WARN >= 3) |
Altman Z'' 4.15
| (A) 0.08 = (Total Current Assets 1.85b - Total Current Liabilities 1.20b) / Total Assets 8.70b |
| (B) 0.57 = Retained Earnings (Balance) 4.99b / Total Assets 8.70b |
| (C) 0.10 = EBIT TTM 796.6m / Avg Total Assets 7.94b |
| (D) 1.06 = Book Value of Equity 4.97b / Total Liabilities 4.68b |
| Total Rating: 4.15 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 71.12
| 1. Piotroski 6.0pt |
| 2. FCF Yield 3.72% |
| 3. FCF Margin 6.91% |
| 4. Debt/Equity 0.80 |
| 5. Debt/Ebitda 3.03 |
| 6. ROIC - WACC (= 2.72)% |
| 7. RoE 13.14% |
| 8. Rev. Trend 98.82% |
| 9. EPS Trend 84.75% |
What is the price of CACI shares?
Over the past week, the price has changed by -3.89%, over one month by -2.42%, over three months by +15.42% and over the past year by +38.27%.
Is CACI a buy, sell or hold?
- Strong Buy: 10
- Buy: 4
- Hold: 1
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the CACI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 658.9 | 15.1% |
| Analysts Target Price | 658.9 | 15.1% |
| ValueRay Target Price | 716.4 | 25.1% |
CACI Fundamental Data Overview December 06, 2025
P/E Trailing = 26.7373
P/E Forward = 20.7469
P/S = 1.5094
P/B = 3.2519
P/EG = 3.38
Beta = 0.583
Revenue TTM = 8.86b USD
EBIT TTM = 796.6m USD
EBITDA TTM = 1.01b USD
Long Term Debt = 2.71b USD (from longTermDebt, last quarter)
Short Term Debt = 68.8m USD (from shortTermDebt, last quarter)
Debt = 3.20b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.07b USD (from netDebt column, last quarter)
Enterprise Value = 16.44b USD (13.37b + Debt 3.20b - CCE 133.0m)
Interest Coverage Ratio = 4.40 (Ebit TTM 796.6m / Interest Expense TTM 181.0m)
FCF Yield = 3.72% (FCF TTM 612.3m / Enterprise Value 16.44b)
FCF Margin = 6.91% (FCF TTM 612.3m / Revenue TTM 8.86b)
Net Margin = 5.69% (Net Income TTM 504.5m / Revenue TTM 8.86b)
Gross Margin = 8.99% ((Revenue TTM 8.86b - Cost of Revenue TTM 8.06b) / Revenue TTM)
Gross Margin QoQ = 9.28% (prev 8.97%)
Tobins Q-Ratio = 1.89 (Enterprise Value 16.44b / Total Assets 8.70b)
Interest Expense / Debt = 1.44% (Interest Expense 46.2m / Debt 3.20b)
Taxrate = 24.86% (41.3m / 166.1m)
NOPAT = 598.6m (EBIT 796.6m * (1 - 24.86%))
Current Ratio = 1.54 (Total Current Assets 1.85b / Total Current Liabilities 1.20b)
Debt / Equity = 0.80 (Debt 3.20b / totalStockholderEquity, last quarter 4.03b)
Debt / EBITDA = 3.03 (Net Debt 3.07b / EBITDA 1.01b)
Debt / FCF = 5.01 (Net Debt 3.07b / FCF TTM 612.3m)
Total Stockholder Equity = 3.84b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.80% (Net Income 504.5m / Total Assets 8.70b)
RoE = 13.14% (Net Income TTM 504.5m / Total Stockholder Equity 3.84b)
RoCE = 12.17% (EBIT 796.6m / Capital Employed (Equity 3.84b + L.T.Debt 2.71b))
RoIC = 8.80% (NOPAT 598.6m / Invested Capital 6.80b)
WACC = 6.07% (E(13.37b)/V(16.57b) * Re(7.27%) + D(3.20b)/V(16.57b) * Rd(1.44%) * (1-Tc(0.25)))
Discount Rate = 7.27% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -33.33 | Cagr: -0.54%
[DCF Debug] Terminal Value 80.79% ; FCFE base≈527.7m ; Y1≈621.7m ; Y5≈954.0m
Fair Price DCF = 740.6 (DCF Value 16.35b / Shares Outstanding 22.1m; 5y FCF grow 18.98% → 3.0% )
EPS Correlation: 84.75 | EPS CAGR: 12.60% | SUE: 1.02 | # QB: 6
Revenue Correlation: 98.82 | Revenue CAGR: 12.20% | SUE: 0.44 | # QB: 0
EPS next Quarter (2026-03-31): EPS=7.14 | Chg30d=-0.223 | Revisions Net=-12 | Analysts=13
EPS current Year (2026-06-30): EPS=28.23 | Chg30d=+0.206 | Revisions Net=+9 | Growth EPS=+6.6% | Growth Revenue=+8.5%
EPS next Year (2027-06-30): EPS=31.54 | Chg30d=+1.028 | Revisions Net=+7 | Growth EPS=+11.7% | Growth Revenue=+6.3%
Additional Sources for CACI Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle